CVRx (CVRX) Revenue Growth (1y) (2021 - 2026)
CVRx (CVRX) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 7.30% |
| 10 | CVRx | 76.89 Mn | 12.31 Mn | 13.72 Mn | 15.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.57% |
| Mar 31, 2026 | 19.61% |
| Dec 31, 2025 | 4.45% |
| Sep 30, 2025 | 9.85% |
| Jun 30, 2025 | 15.09% |
| Mar 31, 2025 | 14.65% |
| Dec 31, 2024 | 35.71% |
| Sep 30, 2024 | 27.23% |
| Jun 30, 2024 | 24.28% |
| Mar 31, 2024 | 34.98% |
| Dec 31, 2023 | 57.54% |
| Sep 30, 2023 | 69.92% |
| Jun 30, 2023 | 88.83% |
| Mar 31, 2023 | 95.76% |
| Dec 31, 2022 | 96.17% |
| Sep 30, 2022 | 82.21% |
| Jun 30, 2022 | 61.10% |
| Mar 31, 2022 | 42.52% |
| Dec 31, 2021 | 75.19% |
| Sep 30, 2021 | 240.52% |